LARS G. EKMAN, M.D., PH.D. - Corporate Board Profile

AMARIN CORP PLC\UK

Filing Date	Source Excerpt
2011-05-02	The following table shows the compensation paid in fiscal 2010 to the Companys non-employee directors. Lars G. Ekman Fees Earned or Paid in Cash $35,462 Option Awards $104,400 Total $139,862
2012-04-27	Dr. Ekman joined Amarin as a non-executive director in November 2008, and was named Amarin's lead independent director in October 2011. ... The Audit Committee is currently comprised of Mr. van Heek (Chairman), Mr. O'Sullivan and Ms. Peterson. ... The Nominating and Corporate Governance Committee is currently comprised of Doctors Gordon (Chairman), Anderson and Ekman. ... The following table shows the compensation paid in fiscal 2011 to the Company's non-employee directors. Lars G. Ekman 33,000.
2013-04-23	Lars G. Ekman joined Amarin as a non-executive director in November 2008, and was named Amarin’s lead independent director in October 2011. The Nominating and Corporate Governance Committee is currently comprised of Doctors Gordon (Chairman), Ekman and Anderson. The following table shows the compensation paid in fiscal 2012 to the Company’s non-employee directors. Lars G. Ekman: $604,680 in 2012.
2014-04-30	Lars G. Ekman, M.D., Ph.D. (2008) 64 Director; Dr. Ekman was named Amarin's lead independent director in October 2011 and Amarin's Chairman of the Board effective January 2014; Nominating and Corporate Governance Committee (Chairman); Director compensation: $121,232
2015-04-24	Dr. Ekman was named Amarin’s lead independent director in October 2011 and Amarin’s Chairman of the Board effective January 2014. ... Currently, the Nominating and Corporate Governance Committee is comprised of Mr. O'Sullivan (Chairman), Dr. Ekman and Ms. Peterson. ... The following table shows the compensation paid in fiscal 2014 to the Company’s non-employee directors. Lars G. Ekman: $201,751.
2017-04-21	Lars G. Ekman M.D., Ph.D. (2008) 67 Director; Dr. Ekman is Chairman of the Board effective January 2014; The Audit Committee is currently comprised of Mr. Van Heek (Chairman), Mr. O'Sullivan and Ms. Peterson; The Nominating and Corporate Governance Committee is currently comprised of Mr. O'Sullivan (Chairman), Dr. Ekman and Mr. Zakrzewski; Director Compensation Table shows Lars G. Ekman compensation as $210,013.
2019-04-25	Lars G. Ekman, M.D., Ph.D. (2008) 69 Director; Chairman of the Board effective January 2014; Nominating and Corporate Governance Committee is currently comprised of Mr. O'Sullivan (Chairman), Mr. Zakrzewski and Dr. Ekman; Audit Committee is currently comprised of Mr. van Heek (Chairman), Mr. O'Sullivan and Ms. Peterson; Director Compensation Table shows Lars G. Ekman total compensation $320,006.
2020-06-01	Dr. Ekman is our Chairman of the Board. Dr. Ekman is independent and all key committees of the Board are comprised solely of, and chaired by, independent directors. The Nominating and Corporate Governance Committee is currently comprised of Mr. O'Sullivan (Chairman), Mr. Zakrzewski and Dr. Ekman. On May 20, 2019, the Company awarded an option to purchase 10,431 ordinary shares and 8,023 restricted stock units to Dr. Ekman in connection with his service on the Board and as Non-Executive Chairman of the Board. The total grant-date fair value of each of these awards is $135,042 and $135,027, respectively. The following table shows the compensation paid in fiscal year 2019 to the Company’s non-employee directors: Lars G. Ekman, M.D., Ph.D. Fees Earned or Paid in Cash: $100,000, Stock Awards: $135,027, Option Awards: $135,042, Total: $370,069.
2021-04-29	Lars G. Ekman joined Amarin as a non-executive director in November 2008 and was named Amarin's lead independent director in October 2011 and Chairman of the Board effective January 2014. He serves on the Nominating and Corporate Governance Committee. Director compensation table shows total compensation of $1,451,195 in 2020.
2022-05-24	Lars G. Ekman, M.D., Ph.D. joined Amarin as a non-executive director in November 2008 and was named Amarin’s lead independent director in October 2011 and then served as Chairman of Amarin’s board of directors from January 2014 to May 2022. The Audit Committee is currently comprised of Ms. Enright (Chairwoman, effective upon her appointment to the Board in May 2022), Mr. van Heek (Chairman until the appointment of Ms. Enright as Chairwoman in May 2022), Mr. O’Sullivan and Ms. Peterson. The Nominating and Corporate Governance Committee is currently comprised of Mr. O’Sullivan (Chairman), Mr. Zakrzewski and Dr. Ekman. The total grant-date fair value of each of these awards is approximately $190,000, based on a closing price of $5.00 on Nasdaq of the ADSs representing the Company’s ordinary shares on the date of grant. Director Compensation Table: Lars G. Ekman, M.D., Ph.D. $100,000 fees earned in cash, $190,000 stock awards, $190,004 option awards, total $480,004; Jan van Heek $97,500 fees earned in cash, $180,000 stock awards, $180,003 option awards, total $457,503; Patrick J. O’Sullivan $85,500 fees earned in cash, $180,000 stock awards, $180,003 option awards, total $445,503; Kristine Peterson $84,500 fees earned in cash, $180,000 stock awards, $180,003 option awards, total $444,503; David Stack $82,500 fees earned in cash, $180,000 stock awards, $180,003 option awards, total $442,503; Joseph S. Zakrzewski $67,500 fees earned in cash, $180,000 stock awards, $180,003 option awards, total $427,503.